Micropos Medical AB

Article about Micropos published in Nordic Life Science Review

Pressmeddelande   •   Nov 29, 2011 15:26 CET

In the most recent edition of the magazine Nordic Life Science Review is a three page article about Micropos Medical and the RayPilot® system for increased precision in radiotherapy of prostate cancer published.

The article describes amoung others:

- One of the largest problems when treating a tumor with radiation is to strike at the right place – tumors move in the human body along with the organs in which they grow. Therefore a bigger area than necessary is irradiated, leading to damage of healthy tissue. The Swedish company Micropos Medical has solved this problem by tracking the tumor with a radio transmitter. The result is a more precise and less time consuming radiotherapy of tumors.

Furthermore, it is mentioned in the article that the RayPilot® system is installed at clinics in Sweden, Denmark and Germany as well as 17 scientific papers have been published so far.

The whole idea of ​​RayPilot ® system is to complement existing radiotherapy equipment in order to achieve a higher precision, which is a need for safely increasing the radiation dose into the tumor (which may increase the chance of curing the patient) while the radiation dose to healthy tissue may be reduced.

Click on the link below in order to read the full text article.

http://micropos.se/images/stories/pdf/Pressreleaser/2011/November/Nordic_Life_Science_Review_2011_Q3_Micropos.pdf

About Micropos Medical AB (publ):

Micropos Medical AB (publ) (www.micropos.se) is a Swedish medical device start-up that was founded in 2003 as a result of four physicians’ long clinical experience in the therapeutic radiation oncology field (cancer treatment). The company has developed the RayPilot® system for increased precision in radiotherapy of prostate cancer. The RayPilot® system is an electromagnetic positioning system that initially enables real time position of the prostate for a fast and objective set-up and for continuous positioning during the treatment. A precise and safe localization of the tumor can dramatically improve the outcome of the treatment, particularly for hypofractionated protocols. The RayPilot® system consists mainly of three parts; a transmitter that is placed in the ROI, a receiving system that is placed directly on any existing treatment coach and software that continuously shows where the tumor is and where to beam. The transmitter is removed after the final treatment in order to enable MRI follow-up.

Now you can follow the company on Facebook, http://www.facebook.com/MicroposMedical